In vitro susceptibility patterns of clinically important Trichophyton and Epidermophyton species against nine antifungal drugs

Mycoses

Volumn 58, Issue 5, 2015, Pages 303-307

  Badali, Hamid ^a   Mohammadi, Rasoul ^b   Mashedi, Olga ^c   de Hoog, G Sybren ^d,e,f,g,h,i   Meis, Jacques F ^j,k  

^a MAZANDARAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b ISFAHAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c KENYA MEDICAL RESEARCH INSTITUTE   (Kenya)

^d CBS KNAW FUNGAL BIODIVERSITY CENTRE   (Netherlands)

^e UNIVERSITY OF AMSTERDAM   (Netherlands)

^f SUN YAT SEN UNIVERSITY   (China)

^g PEKING UNIVERSITY HEALTH SCIENCE CENTER   (China)

^h FEDERAL UNIVERSITY OF PARANÁ   (Brazil)

ⁱ KING ABDULAZIZ UNIVERSITY   (Saudi Arabia)

^j RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^k CANISIUS WILHELMINA HOSPITAL   (Netherlands)

more..

Author keywords

E. floccosum; ITS rDNA; Antifungal susceptibility; Dermatophytosis; Trichophyton species

Indexed keywords

AMPHOTERICIN B; ANIDULAFUNGIN; ANTIFUNGAL AGENT; CASPOFUNGIN; FLUCONAZOLE; INTERNAL TRANSCRIBED SPACER; ISAVUCONAZOLE; ITRACONAZOLE; POSACONAZOLE; RIBOSOME DNA; TERBINAFINE; VORICONAZOLE; ECHINOCANDIN; NAPHTHALENE DERIVATIVE; NITRILE; PYRIDINE DERIVATIVE; TRIAZOLE DERIVATIVE;

ANTIFUNGAL ACTIVITY; ANTIFUNGAL SUSCEPTIBILITY; ARTICLE; BROTH DILUTION; CONTROLLED STUDY; DERMATOPHYTOSIS; DNA SEQUENCE; EPIDERMOPHYTON; EPIDERMOPHYTON FLOCCOSUM; FUNGAL STRAIN; FUNGUS ISOLATION; HUMAN; IN VITRO STUDY; MINIMUM INHIBITORY CONCENTRATION; PRIORITY JOURNAL; TRICHOPHYTON; TRICHOPHYTON MENTAGROPHYTES; TRICHOPHYTON RUBRUM; TRICHOPHYTON VERRUCOSUM; CLASSIFICATION; DRUG EFFECTS; MICROBIAL SENSITIVITY TEST; MICROBIOLOGY; TINEA;

ARTHRODERMATACEAE; EPIDERMOPHYTON; EPIDERMOPHYTON FLOCCOSUM; TRICHOPHYTON; TRICHOPHYTON RUBRUM; TRICHOPHYTON SCHOENLEINII; TRICHOPHYTON VERRUCOSUM;

AMPHOTERICIN B; ANTIFUNGAL AGENTS; ECHINOCANDINS; EPIDERMOPHYTON; FLUCONAZOLE; HUMANS; ITRACONAZOLE; MICROBIAL SENSITIVITY TESTS; NAPHTHALENES; NITRILES; PYRIDINES; TINEA; TRIAZOLES; TRICHOPHYTON; VORICONAZOLE;

EID: 84937629330     PISSN: 09337407     EISSN: 14390507     Source Type: Journal    
DOI: 10.1111/myc.12315     Document Type: Article

References (19)

1. Havlickova A, Czaika VA, Friedrich M. Epidemiological trends in skin mycoses worldwide. Mycoses 2008; 51(suppl 4): 2-15.
2. Ghannoum M, Isham N. Fungal nail infections (onychomycosis): a never-ending story? PLoS Pathog 2014; 10: e1004105. doi:10.1371/journal.ppat.1004105.
3. Gong JQ, Liu XQ, Zeng XS, Li XF. Deep dermatophytosis caused by Trichophyton rubrum: report of two cases. Mycoses 2007; 50: 102-8.
4. Bhatta AK, Huang X, Keyal U, Zhao JJ. Laser treatment for onychomycosis: a review. Mycoses 2014; 57: 734-40.
5. Succi IB, Bernardes-Engemann AR, Orofino-Costa R. Intermittent therapy with terbinafine and nail abrasion for dermatophyte toe onychomycosis: a pilot study. Mycoses 2013; 56: 327-32.
6. Mukherjee PK, Leidich SD, Isham N, Leitner I, Ryder NS, Ghannoum MA. Clinical Trichophyton rubrum strain exhibiting primary resistance to terbinafine. Antimicrob Agents Chemother 2003; 47: 82-86.
7. Fernández-Torres B, Vázquez-Veiga H, Liovo X, Pereiro Jr M, Guarro J. In vitro susceptibility to itraconazole, clotrimazole, ketoconazole and terbinafine of 100 isolates of Trichophyton rubrum. Chemother 2000; 46: 390-4.
8. Fernández-Torres B, Carrillo AJ, Martín E etal. In vitro activities of 10 antifungal drugs against 508 dermatophyte strains. Antimicrob Agents Chemother 2001; 45: 2524-8.
9. Georgii A, Korting HC. Antifungal susceptibility testing with dermatophytes. Mycoses 1991; 34: 193-9.
10. da Silva Barros ME, de Assis Santos D, Hamdan J. Evaluation of susceptibility of Trichophyton mentagrophytes and Trichophyton rubrum clinical isolates to antifungal drugs using a modified CLSI microdilution method (M38-A). Med Microbiol 2007; 56: 514-8.
11. de Hoog GS, Guarro J, Gene J, Figueras MJ. Atlas of Clinical Fungi. 2nd edn. Utrecht: Centraalbureau voor Schimmelcultures, 2000.
12. Li HC, Bouchara JP, Hsu MM, Barton R, Su S, Chang TC. Identification of dermatophytes by sequence analysis of the rRNA gene internal transcribed spacer regions. J Med Microbiol 2008; 57(Pt 5): 592-600.
13. Clinical and Laboratory Standards Institute (CLSI). Reference Method for Broth Dilution Antifungal Susceptibility Testing of Filamentous Fungi. Approved Standard M38-A2, 2nd edn. Wayne, PA: Clinical and Laboratory Standards Institute, 2008.
14. Rezaei-Matehkolaei A, Mirhendi H, Makimura K etal. Nucleotide sequence analysis of beta tubulin gene in a wide range of dermatophytes. Med Mycol 2014; 52: 672-88.
15. Rezaei-Matehkolaei A, Makimura K, De Hoog GS etal. Discrimination of Trichophyton tonsurans and Trichophyton equinum by PCR-RFLP and by β-tubulin and Translation Elongation Factor 1-α sequencing. Med Mycol 2012; 50: 760-4.
16. Irimie M, Tătaru A, Oantă A, Moga M. In vitro susceptibility of dermatophytes isolated from patients with end-stage renal disease: a case-control study. Mycoses 2014; 57: 129-34.
17. Biancalana FS, Telles PF, Lyra L, Schreiber AZ. Preanalytical conditions for broth microdilution antifungal susceptibility of Microsporum spp. Mycoses 2008; 51: 313-7.
18. Jo Siu WJ, Tatsumi Y, Senda H etal. Comparison of invitro antifungal activities of efinaconazole and currently available antifungal agents against a variety of pathogenic fungi associated with onychomycosis. Antimicrob Agents Chemother 2013; 57: 1610-6.
19. Bao YQ, Wan Z, Li RY. In vitro antifungal activity of micafungin and caspofungin against dermatophytes isolated from China. Mycopathologia 2013; 175: 141-5.